CIBC Asset Management Inc Buys 7,477 Shares of Henry Schein, Inc. $HSIC

CIBC Asset Management Inc grew its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 47.8% in the 4th quarter, Holdings Channel.com reports. The firm owned 23,135 shares of the company’s stock after purchasing an additional 7,477 shares during the period. CIBC Asset Management Inc’s holdings in Henry Schein were worth $1,749,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Assenagon Asset Management S.A. lifted its stake in shares of Henry Schein by 212.8% during the 4th quarter. Assenagon Asset Management S.A. now owns 67,181 shares of the company’s stock worth $5,078,000 after acquiring an additional 45,701 shares during the last quarter. Kettle Hill Capital Management LLC bought a new stake in shares of Henry Schein during the 3rd quarter worth approximately $14,158,000. Tudor Investment Corp ET AL bought a new stake in shares of Henry Schein during the 3rd quarter worth approximately $15,375,000. Snyder Capital Management L P lifted its stake in shares of Henry Schein by 18.6% during the 3rd quarter. Snyder Capital Management L P now owns 1,334,364 shares of the company’s stock worth $88,562,000 after acquiring an additional 209,123 shares during the last quarter. Finally, SG Americas Securities LLC lifted its stake in shares of Henry Schein by 171.9% during the 4th quarter. SG Americas Securities LLC now owns 820,698 shares of the company’s stock worth $62,028,000 after acquiring an additional 518,914 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

Henry Schein Trading Up 0.8%

Shares of NASDAQ:HSIC opened at $78.05 on Tuesday. The company has a market capitalization of $8.89 billion, a PE ratio of 23.58, a P/E/G ratio of 1.49 and a beta of 0.82. The company has a current ratio of 1.36, a quick ratio of 0.75 and a debt-to-equity ratio of 0.59. Henry Schein, Inc. has a 12-month low of $61.94 and a 12-month high of $89.29. The business’s fifty day simple moving average is $74.79 and its 200-day simple moving average is $76.01.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.20 by $0.12. The firm had revenue of $3.37 billion during the quarter, compared to analysts’ expectations of $3.34 billion. Henry Schein had a return on equity of 15.44% and a net margin of 2.95%.The firm’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.15 EPS. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. As a group, equities research analysts predict that Henry Schein, Inc. will post 5.32 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on HSIC. Robert W. Baird set a $97.00 price target on Henry Schein in a research note on Wednesday, May 6th. Citigroup began coverage on shares of Henry Schein in a research note on Wednesday, April 15th. They issued a “buy” rating and a $100.00 target price on the stock. Morgan Stanley restated an “underweight” rating and issued a $64.00 target price (up from $61.00) on shares of Henry Schein in a research note on Friday, April 24th. Leerink Partners restated a “market perform” rating on shares of Henry Schein in a research note on Monday, March 9th. Finally, Wall Street Zen downgraded shares of Henry Schein from a “strong-buy” rating to a “buy” rating in a research note on Sunday, April 26th. Six research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Henry Schein presently has an average rating of “Hold” and an average target price of $86.83.

Insiders Place Their Bets

In related news, Director William K. Daniel acquired 10,000 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The stock was purchased at an average cost of $69.19 per share, for a total transaction of $691,900.00. Following the purchase, the director directly owned 20,000 shares of the company’s stock, valued at $1,383,800. This trade represents a 100.00% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Thomas C. Popeck sold 1,355 shares of the company’s stock in a transaction on Thursday, March 19th. The stock was sold at an average price of $72.79, for a total value of $98,630.45. Following the sale, the chief executive officer owned 86,182 shares of the company’s stock, valued at $6,273,187.78. This trade represents a 1.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.89% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.